- Home
- AKYA vs AVTE Comparison
AKYA vs AVTE Comparison
Compare AKYA & AVTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKYA
- AVTE
- Stock Information
- Founded
- AKYA 2015
- AVTE 2018
- Country
- AKYA United States
- AVTE United States
- Employees
- AKYA N/A
- AVTE N/A
- Industry
- AKYA Medical Specialities
- AVTE Biotechnology: Pharmaceutical Preparations
- Sector
- AKYA Industrials
- AVTE Health Care
- Exchange
- AKYA Nasdaq
- AVTE Nasdaq
- Market Cap
- AKYA 84.7M
- AVTE 72.5M
- IPO Year
- AKYA 2021
- AVTE 2021
- Fundamental
- Price
- AKYA $1.35
- AVTE $2.51
- Analyst Decision
- AKYA Buy
- AVTE Hold
- Analyst Count
- AKYA 7
- AVTE 7
- Target Price
- AKYA $3.26
- AVTE $11.75
- AVG Volume (30 Days)
- AKYA 251.7K
- AVTE 64.3K
- Earning Date
- AKYA 05-12-2025
- AVTE 03-27-2025
- Dividend Yield
- AKYA N/A
- AVTE N/A
- EPS Growth
- AKYA N/A
- AVTE N/A
- EPS
- AKYA N/A
- AVTE N/A
- Revenue
- AKYA $81,672,000.00
- AVTE N/A
- Revenue This Year
- AKYA $13.94
- AVTE N/A
- Revenue Next Year
- AKYA $14.48
- AVTE N/A
- P/E Ratio
- AKYA N/A
- AVTE N/A
- Revenue Growth
- AKYA N/A
- AVTE N/A
- 52 Week Low
- AKYA $1.32
- AVTE $1.25
- 52 Week High
- AKYA $4.65
- AVTE $30.29
- Technical
- Relative Strength Index (RSI)
- AKYA 29.49
- AVTE 52.00
- Support Level
- AKYA $1.32
- AVTE $2.45
- Resistance Level
- AKYA $1.78
- AVTE $2.56
- Average True Range (ATR)
- AKYA 0.14
- AVTE 0.09
- MACD
- AKYA 0.01
- AVTE 0.00
- Stochastic Oscillator
- AKYA 6.52
- AVTE 77.14
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.